02:02 PM EDT, 08/13/2024 (MT Newswires) -- Ocuphire Pharma ( OCUP ) shares fell more than 18% in recent trading Tuesday after the clinical-stage ophthalmic biopharmaceutical company posted a wider quarterly loss and lower revenue.

The company reported a Q2 net loss earlier in the day of $0.30 per share, widening from $0.24 loss a year earlier.

Analysts polled by Capital IQ also expected a loss of $0.30.

License and collaborations revenue for the quarter ended June 30 was $1.1 million, down from $3.7 million a year earlier.

Analysts polled by Capital IQ expected $1.9 million.

Price: 1.35, Change: -0.31, Percent Change: -18.43